Allworth Financial’s Heron Therapeutics HRTX Stock Holding History

Allworth Financial’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.62K	Buy	9,523 +194	+2%	+$225	﹤0.01%	3687
2025 Q4	$12.1K	Buy	9,329 +7,775	+500%	+$9.6K	﹤0.01%	3139
2025 Q3	$1.96K	Buy	1,554 +1,519	+4,340%	+$2.41K	﹤0.01%	4012
2025 Q2	$73	Buy	+35	New	+$71	﹤0.01%	4416
2024 Q4	–	Sell	-301	Closed	-$599	–	3995
2024 Q3	$599	Hold	301	–	–	﹤0.01%	3372
2024 Q2	$979	Hold	301	–	–	﹤0.01%	3169
2024 Q1	$834	Hold	301	–	–	﹤0.01%	3138
2023 Q4	$512	Buy	+301	New	+$331	﹤0.01%	3126
2021 Q4	–	Sell	-150	Closed	-$2K	–	2023
2021 Q3	$2K	Hold	150	–	–	﹤0.01%	1681
2021 Q2	$2K	Hold	150	–	–	﹤0.01%	1373
2021 Q1	$2K	Hold	150	–	–	﹤0.01%	1305
2020 Q4	$3K	Buy	+150	New	+$2.61K	﹤0.01%	1079

Other funds holding HRTX

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return